A GLP-1 controls how much goes in. What that does to muscle depends on three inputs that have nothing to do with the compound in the vial.
For educational and research purposes only. This is not medical advice and is not human-use guidance. Consult a qualified professional before acting on anything here.
Start here
Why a deficit costs muscle, and why the early flat look usually is not muscle
The body does not sort fat from muscle when it runs a sustained caloric deficit. It burns whatever is available. A GLP-1 is built to control intake, meaning it reduces food noise, slows gastric emptying, and lowers appetite. That is the job it was designed for. The part it does not do on its own is tell the body that muscle should be kept.
This is not a compound failure. It is a predictable response to eating less when two signals are missing: enough protein as raw material, and a training stimulus telling the body its muscle is being used and should be maintained. Without those, a deep deficit reads muscle tissue as available fuel.
Weight loss and fat loss are not the same thing. The scale dropping does not confirm that lean mass is being protected.
The early flat look is usually not muscle
Most researchers misread the first signal. A flat or soft appearance in the first two to four weeks of a GLP-1 protocol is almost always water and glycogen leaving, not muscle. Glycogen, which is stored carbohydrate, holds roughly three grams of water for every gram stored. When intake drops sharply the body burns through glycogen quickly and that water leaves with it, which produces a deflated look that has nothing to do with tissue.
Confirmed lean mass loss is a reduction in muscle tissue, not a number on a scale. The distinction matters because the response to each is completely different. Use the explorer below to see what the early deflated look is most likely made of, and when actual tissue loss becomes the more probable reading.
Weeks 1 to 4Later, and only under conditions
The takeaway from the explorer is the whole reason this guide leads with it. The first few weeks are the worst time to judge muscle, because the loudest change on the scale is the change that has nothing to do with muscle. The rest of the guide is about reading the signal that does, and protecting the tissue before the reading turns bad.
Free — no payment required
Read the rest of the guide
One email opens this guide and every other free research guide on the site. If you have already given your email anywhere on Project Theo, this will not appear again.
No spam. Used only for research guide access and occasional protocol updates from Project Theo.
Part two
Is it actually happening
Measurable lean mass loss means a confirmed reduction in muscle tissue, not a lower number on a bathroom scale. Body weight moves daily from water, food volume, and glycogen, so the scale on its own is not a reliable lean mass signal in either direction. The methods below are listed in order of reliability.
Method
What it tells you
When to use it
DEXA scan
A precise breakdown of fat mass, lean mass, and bone density by compartment. The most direct read of tissue change.
Baseline and roughly every twelve weeks, where available.
Skinfold calipers
Directionally reliable when measured at the same sites, same time of day, by the same measurer each time.
Weekly, under consistent conditions.
Limb and waist measurements
A trend rather than a single number. A flat or rising scale with shrinking limbs is a lean mass warning regardless of what total bodyweight is doing.
Weekly, when DEXA and calipers are unavailable.
The limb measurement trend over two to three weeks is a better early indicator than any single weigh-in. The decision path below works from that idea. It reads what your tracking is showing and returns the variable to look at next. It does not return a compound, a dose, or a protocol, because those depend on things not visible from here.
Question one
Over the last two to three weeks, what has the scale been doing?
What this points at
Question two
Over the same window, what are limb and waist measurements doing? This is the reading that carries the most weight here.
Research points to three variables as the primary determinants of lean mass during a caloric deficit. All three sit before any compound decision, because adding a support compound on top of a deficiency in one of these produces a weaker result than correcting the input first.
Protein, the raw material
Lean mass preservation needs protein as building material. Research reference points for a deficit sit at roughly 0.7 to 0.8 grams per pound of bodyweight. Below that range, research suggests protection becomes harder to hold, and no compound substitutes for the raw material. This is the first thing to audit, because GLP-1 appetite suppression tends to cut not just total calories but protein along with them. Someone eating 160 grams at maintenance can drift to 90 without noticing.
A GH secretagogue improves the signaling environment for lean mass, but improved signaling in a low-protein setting is a better blueprint with no building materials. The outcome does not change.
Training stimulus, the reason to keep it
Muscle is metabolically expensive. If the body has no reason to hold it, it removes it. Resistance training creates a demand signal that says muscle capacity is being used and should be maintained. Without that signal the preservation response drops sharply, even with the right compounds running. The training does not need to be extreme. It needs to be consistent, and it needs to be resistance work rather than cardio alone.
Sleep, the input that overrides the rest
Much of the body's growth hormone release happens during deep sleep. A GH secretagogue stimulates release, but sleep architecture is a variable it cannot override. Short or fragmented sleep raises cortisol and flattens the hormonal rhythms that make lean mass preservation possible, so a support protocol run on five to six hours of poor sleep is working against the mechanism before it arrives.
The audit below is the part a PDF could not do. Check the inputs that are genuinely in place right now. The read updates as you go, names the ones that are not, and saves to this device so you can come back to it as the protocol runs.
Three inputs audit
Protein is at or above the research reference range most daysRoughly 0.7 to 0.8 grams per pound. GLP-1 appetite suppression tends to pull this down first, so it is the first variable to audit.
Resistance training is consistent, not cardio aloneThis is the demand signal that gives the body a reason to keep muscle. Consistent matters more than extreme.
Sleep is stable and mostly undisruptedDeep sleep is where much of natural GH release happens. No compound overrides poor sleep architecture.
Your read
Nothing checked yet. Work through the three inputs above and a read will appear here.
Prevention versus correction, and what GH secretagogues actually do
Support added early, while the three inputs are still being set, is prevention. Support added after muscle loss is visually obvious is correction. Prevention is easier, and the reason is simple: by the time loss is obvious, weeks of tissue have already gone that a deficit alone cannot replace, the physique flattens further, training performance drops, and the deficit gets harder to sustain.
The common mistake is treating lean mass support as an emergency response after visible loss rather than as part of the plan from the start. Once loss is confirmed, the correction phase is meaningfully harder than the prevention phase would have been. Research frames the decision as one of timing rather than of finding a stronger compound after the fact.
Prevention is easier than correction. Support while the inputs are being set is a protocol decision. Support after visible loss is damage control.
What a GH secretagogue is
A GH secretagogue is a compound that stimulates the body's own growth hormone production rather than replacing it from outside. It works with the existing signaling system, which is why it carries a different profile than exogenous growth hormone, meaning growth hormone introduced directly. The two research-supported options for lean mass preservation during a GLP-1 protocol are below, framed by what each is for rather than by which is stronger, because a strength ranking is not a question a page can answer for an individual.
Two pathways — sharper pulse
CJC 1295 (no DAC) + Ipamorelin
These two act on different receptors in the growth hormone pathway. CJC 1295 without DAC mimics the signaling peptide that tells the pituitary to release growth hormone. DAC refers to Drug Affinity Complex, an attachment that extends half-life, and the version without it keeps the release pattern closer to a natural pulse. Ipamorelin works through a separate receptor and amplifies the pulse. Research supports the two together producing more growth hormone output than either alone.
Most human trial data
Tesamorelin + Ipamorelin
Tesamorelin has the most extensive human clinical trial data of any compound in this category. It was developed and approved for a specific medical application, which gives it a documented safety and efficacy profile the other secretagogues do not have. Research data suggests it preserves lean mass during a caloric deficit and supports visceral fat reduction when the primary protocol is already working.
What tesamorelin is and is not. Tesamorelin is characterized in the research as a muscle protector, not a muscle builder. Anyone expecting an anabolic, tissue adding response will be disappointed. Used to protect a cut and preserve tissue quality, it does what the data describes. Where a specific compound, dose, or timing belongs is an individual decision that sits with a qualified prescriber and a personalized read, not with a page.
Part five
When the inputs are handled and loss continues
If protein is at the reference range, training is consistent, sleep is reasonably stable, and support was in place early, and confirmed muscle loss is still happening, the issue is most likely not which compound is being run.
What a general framework cannot see from the outside is the specific sequence and timing in a protocol: how compounds are ordered, how long each phase runs, and how recovery and metabolic adaptation interact at that level. That is a personalized diagnostic read rather than a different compound recommendation, and it is the point at which a written analysis against your actual inputs does something a guide cannot.
A common wrong turn. Escalating the primary GLP-1 dose during a period of confirmed lean mass loss tends to deepen the deficit and can accelerate tissue breakdown. Adding more intake suppression when muscle loss is the active bottleneck addresses the wrong variable. When the scale stalls, research suggests checking protein, training, and sleep before reaching for a higher dose, because the dose is rarely the variable that a lean mass problem turns on.
Prevention is easier than correction. A flat or rising scale with shrinking limbs is a lean mass warning regardless of what total bodyweight is doing.
Take it with you
The original guide as a PDF
The page is the current version and reflects the framework as it stands now. The PDF is the takeaway if you want it offline.
Not sure which variable is actually limiting your result?
The Protocol Bottleneck Tool maps your exact situation across seven bottleneck categories and tells you where the friction most likely is. It does not ask which compound you are on. It takes about three minutes and it is free.
